An observational study in Chronic Heart Failure, sponsored by University of Kansas. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-09-25.
Sponsored by University of Kansas · Observational
The primary purpose of this study is to compare the time, risk and cost savings of 2 patient groups who receive FDA approved left ventricular pacing leads.
The purpose of this study is to: a) examine the usefulness of placing an epicardial LV lead at the time of open chest surgery in patients who are likely to benefit from a CRT system following their surgery; b) compare differences between patients who receive LV leads using the transvenous approach and those patients who receive LV leads using the epicardial approach; and c) assess the cost effectiveness of placing the LV lead via the transvenous versus the epicardial approaches.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
This study's enrollment of 40 is below the median of 200 across 1,679 observational studies indexed under Heart Failure.
Browse Heart Failure studies →University of Kansas is the lead sponsor of 81 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Medical Center
Exclusion Criteria:
Epicardial left ventricular lead placement during a clinically indicated open chest surgery
Procedure: Epicardial left ventricular lead placement
Transvenous left ventricular lead implant during a clinically indicated CRT system implant
Procedure: Transvenous left ventricular lead implant
Epicardial left ventricular lead placement
Transvenous left ventricular lead implant
This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Kansas